Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ EFFECT - Notice of Effectiveness Filed: 2015-09-17 AccNo: 9999999995-15-002534 Size: 1 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ EFFECT - Notice of Effectiveness Filed: 2015-09-17 AccNo: 9999999995-15-002528 Size: 1 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-09-30 AccNo: 0001193125-15-333982 Size: 365 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2015-09-21 AccNo: 0001193125-15-324146 Size: 3 MB 网页链接